The subspecialties provided by the unit are:
services of this Department have many firsts to its
credit, having done pioneering work in vascular angiopathies such
as branch retinal vein occlusion, Central serous choroidopathy,
clinical advances have been - the role of silicone oil in
endophthalmitis, the role of intravitreal triamcinolone actonide,
(IVTA), and intravitreal avastin.
Advances in the
management of uveitis, include trials with Retisert implant and a
new technique for posterior subtenon injections. Improvements in
the management of age related macular degeneration and choroidal
neovascular membrane have encompassed trials with intravitreal
Avastin, transpupillary thermotherapy, photodynamic therapy and
transscleral Diode laser.